Inching towards precision medicine for multiple myeloma with causal network models.

被引：0
|
作者：
Zhu, Jun
Liu, Yu
Wang, Li
Yu, Haocheng
Yoo, Seungyeul
Lee, Eunjee
Schadt, Eric E.
机构：
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[2] Sema4 Genom, Mt Sinai Venture, Stamford, CT USA
[3] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19526
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine
    Zhang, Peng
    Zhang, Dingfan
    Zhou, Wuai
    Wang, Lan
    Wang, Boyang
    Zhang, Tingyu
    Li, Shao
    BRIEFINGS IN BIOINFORMATICS, 2024, 25 (01)
  • [32] Bayesian Network Models of Multiple Myeloma: Drivers of High Risk and Durable Response
    Gruber, Fred
    Keats, Jonathan J.
    McBride, Kyle
    Runge, Karl
    Wuest, Diane
    Hadzi, Tiffany
    Derome, Mary
    Lonial, Sagar
    Khalil, Iya
    Hayete, Boris
    Auclair, Daniel
    BLOOD, 2016, 128 (22)
  • [33] Evaluating Physician-AI Interaction for Multiple Myeloma Management: Paving the Path Towards Precision Oncology
    Lam, Barbara D.
    Hussain, Zeshan
    Acosta-Perez, Fernando A.
    Bin Riaz, Irbaz
    Jacobs, Maia
    Yee, Andrew J.
    Sontag, David
    BLOOD, 2023, 142
  • [34] Advanced Pediatric Diffuse Pontine Glioma Murine Models Pave the Way towards Precision Medicine
    Chen, Zirong
    Peng, Peng
    Zhang, Xiaolin
    Mania-Farnell, Barbara
    Xi, Guifa
    Wan, Feng
    CANCERS, 2021, 13 (05) : 1 - 17
  • [35] Imaging flow cytometry-based multiplex FISH for three IGH translocations for the precision medicine in multiple myeloma
    Kuroda, Junya
    Tsukamoto, Taku
    Kinoshita, Masaki
    Yamada, Kazuhiro
    Inazawa, Johji
    CANCER SCIENCE, 2022, 113
  • [36] The telomerase template antagonist GRN163L in combination with chemotherapeutics reduces tumor volume in multiple myeloma xenograft models.
    Ertem, SA
    Wu, KD
    Ponomarev, V
    Chin, AC
    Moore, MAS
    BLOOD, 2005, 106 (11) : 971A - 971A
  • [37] TOWARDS PERSONALIZED MEDICINE USING A NOVEL PRECLINICAL MODEL: IDENTIFYING DARATUMUMAB AS EFFECTIVE TREATMENT FOR MULTIPLE MYELOMA
    Noort, W.
    Groen, R.
    Raymakers, R.
    Prins, H.
    Aalders, L.
    Hofhuis, F.
    van Kessel, B.
    Moerer, P.
    Rozemuller, H.
    de Bruijn, J.
    de Weers, M.
    Schuringa, J.
    Parren, P.
    Lokhorst, H.
    Mutis, T.
    Martens, A.
    HAEMATOLOGICA, 2012, 97 : 438 - 438
  • [38] Towards the Molecular Understanding of PCOS Pathogenesis by RNA-seq Analysis of Multiple Tissues of Two Rat PCOS Models.
    Lin, Qiong
    Mueller, Joerg
    Fritsch, Martin
    Lesche, Ralf
    Kageyama, Jorge
    Zollner, Thomas M.
    REPRODUCTIVE SCIENCES, 2021, 28 (SUPPL 1) : 295A - 295A
  • [39] Towards the Molecular Understanding of PCOS Pathogenesis by RNA-seq Analysis of Multiple Tissues of Two Rat PCOS Models.
    Lin, Qiong
    Mueller, Joerg
    Fritsch, Martin
    Lesche, Ralf
    Kageyama, Jorge
    Zollner, Thomas M.
    REPRODUCTIVE SCIENCES, 2020, 27 (SUPPL 1) : 187A - 187A
  • [40] levraging immunosenescence cellular signatures to evaluate the "immune-age": moving towards precision medicine in multiple sclerosis
    Touil, Hanane
    Fujita, Masashi
    Lee, Annie
    Habeck, Christian
    Zuroff, Leah
    Klotz, Luisa
    Xia, Zongqi
    Wiendl, Heinz
    Bar-Or, Amit
    Stern, Yaakov
    De Jager, Philip
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1150 - 1150
12345